Braveheart Investment Share Price (BRH)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Braveheart Inv	LSE:BRH	London	Ordinary Share	GB00B13XV322	ORD 2P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+1.00p	+6.45%	16.50p	37,133	09:52:10

Bid Price		Offer Price	High Price	Low Price	Open Price
16.00p		17.00p	16.75p	16.50p	16.50p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Equity Investment Instruments	0.82	1.49	5.51	3.0	4.5

Related Shares
Scottish Mortgage (SMT), Etfs Phy PM B ?? (PHPP), Octopus 3 (OCV3), Octopus 4 (OCV4)

Braveheart Investment (BRH) Latest News (3)

Braveheart Investment News

Date	Time	Source	Headline
16/7/2018	10:08	ALNC	Braveheart Investment In Talks For New Mezzanine Fund Launch
16/7/2018	07:31	ALNCF	Alliance News Flash Headline
16/7/2018	07:00	UKREG	Braveheart Investment Group plc Update on fund management business
12/7/2018	12:37	ALNC	Braveheart Investee Paraytec To Raise GBP4 Million Via Equity Issue
12/7/2018	07:00	UKREG	Braveheart Investment Group plc Proposed funding round by Paraytec Limited
10/7/2018	10:45	UKREG	Braveheart Investment Group plc Holding(s) in Company
25/6/2018	07:00	UKREG	Braveheart Investment Group plc Further re. Notice of Annual General..
21/6/2018	17:16	UKREG	Braveheart Investment Group plc Confirmation of Posting
20/6/2018	10:30	UKREG	Braveheart Investment Group plc Appointment of Joint Broker
18/6/2018	16:51	ALNC	Braveheart Seeking To Cancel Share Premium And Create Dividend Reserve

More Braveheart Investment News

Braveheart Investment Takeover Rumours

Braveheart Investment (BRH) Share Charts

1 Year Braveheart Investment Chart

1 Month Braveheart Investment Chart

Intraday Braveheart Investment Chart

Braveheart Investment (BRH) Discussions and Chat

Braveheart Investment Forums and Chat

Date	Time	Title	Posts
15/6/2018	11:41	Braveheart Investment Group 2012	95
09/2/2012	12:31	BRAVEHEART: PURE VALUE	36
09/2/2012	11:08	BRAVEHEART INV GROUP ;;;; Uni Funds	23

Add a New Thread

Braveheart Investment (BRH) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2018-07-16 08:51:52	16.50	6,333	1,044.95	O
2018-07-16 08:38:06	16.50	1,400	231.00	O
2018-07-16 08:17:50	16.90	10,000	1,690.00	O
2018-07-16 08:04:16	17.00	1,400	238.00	O
2018-07-16 07:58:58	17.00	10,000	1,700.00	O

View all Braveheart Investment trades in real-time

Braveheart Investment (BRH) Top Chat Posts

Date	Subject
16/7/2018 09:20	Braveheart Investment Daily Update: Braveheart Inv is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker BRH. The last closing price for Braveheart Investment was 15.50p. Braveheart Inv has a 4 week average price of 14.50p and a 12 week average price of 14.50p. The 1 year high share price is 23.88p while the 1 year low share price is currently 14.50p. There are currently 27,082,565 shares in issue and the average daily traded volume is 22,532 shares. The market capitalisation of Braveheart Inv is £4,468,623.23. Read Full Thread Reply
09/1/2017 22:04	swizz: bf, welcome aboard and good to have another poster, unfortunately TB is not at his best during media interviews, which is in complete contrast when he is one to one, the turn around since TB took the reigns is seriously impressive and bodes well for the future, there is some great things happening at Kirkstall, Paraytec, DI4D, Pyreos, Gyrometric, Viking, Vascular Flow, with the added bonus that everyone of them is producing and generating revenue, .....GL S Braveheart Investment keeping the momentum going INVESTMENT OVERVIEW: BRH THE BIG PICTURE Braveheart seeks to back nascent technology companies and work closely with their boards It is hard sometimes to value an investment company like Braveheart Investment Group PLC (LON:BRH), which plays the long game, backing promising technology businesses. Then, along comes a “value realisation” moment, as they call it in the trade, and things get a bit clearer. Such was the case in July, when the company announced it was in advanced talks to dispose of a stake in one of its investee companies, mLED Limited. The share price doubled, and though it came off the boil after the sales was confirmed in September, the shares are still up a very handy 77% over the last year. The group has a 1.25% direct holding and 3.75% stake held through subsidiary Strathclyde Investment Fund in mLED. Proceeds from the sale were £399,000 in cash compared to a book value of £96,000. The money went in the kitty, to invest in more promising technology companies. Talking of which … shares were on the rise again in January 2017 as the company took a 47% stake in Gyrometric Systems Limited, an engineering firm using technology developed at Nottingham Trent University. Gyrometric provides monitoring technology that measures the performance of drive shafts in a wide variety of applications. In effect, the technology tunes the devices, enabling them to operate at maximum efficiency, thereby saving energy, maintenance and capital costs. The large stake taken by Braveheart represents a continuation of the change of strategy by Braveheart, with the company gaining in confidence and backing its judgement more heavily. Not that Gyrometric seems like a particularly risky investment. Braveheart said Gyrometric already has established sales partners in Germany and Asia on which it will now build and expects to break-even in 2017. Selling a stake in a company provides a nice occasional bonus for the company, but the steady income is provided by its wholly-owned subsidiary, Viking Fund Managers. Viking's main fund management income comes from the Finance Yorkshire Equity Fund contract, but it also provides specialist fund management services to other funds that are in 'run-out' mode. This specialised management work tends to generate enhanced fees in excess of standard fund management fees due to the intensive nature of this work. The emphasis for the FYEF is now on portfolio management rather than in seeking new investments and the unit is seeking to win the management contracts for further funds. Viking was recently awarded an additional sum of £2 million of new capital to invest through the existing FYED contract, which means that the investment phase of this contract has been extended into 2017 – March, to be precise. Once this extended investment phase of the contract is completed, Viking will concentrate on realising fund investments with this part of the management contract expected to be completed during 2019. Viking was not successful in winning a fund management contract for the initial phase of the new Northern Powerhouse Investment Fund initiative; however it continues to work with a number of third parties with a view to gaining new fund management contracts. Interim results for the whole group released in October revealed costs were cut in half from a year earlier, which meant pre-tax profits for the six months to September 30 of £475,000 were the largest since the company floated more than eight years ago. They were achieved on revenues of £562,000 and compared with a loss in the comparable period last year of just over £1mln. Overheads fell from £868,000 to £435,000. The comp recently took on 33% of Paraytec, a York-based scientific instruments specialist, and 28% of Kirkstall, which makes equipment for cell tissue labs. Both companies are performing well, either meeting or exceeding internal targets set for them. Sales have now begun of Paraytec's ActiPix D200 system, which was recently introduced into the global pharmaceutical market, Braveheart revealed. Sirius Analytical, one of the first ActiPix licensees, has successfully launched a new drug dissolution imager, incorporating ActiPix technology. It has already met with strong interest from global research laboratories that are interested in licensing the ActiPix wizardry, Braveheart said. The royalties generated from such licences are expected to comprise the majority of Paraytec's future income. Meanwhile, sales of Kirkstall’s 'organ-on-a-chip` system, Quasi Vivo, are ahead of forecast. Research group Research and Markets estimates that the global `organ-on-a-chip` market is poised to grow at a compound annual growth rate of around 69% over the next decade to reach about US$6.13 billion by 2025. Read Full Thread Follow Reply
09/2/2012 11:08	samuelchristo: Good afternoon all - I posted this on another thread: If I may I'd like to bring people's attention to Braveheart Investment Group (BRH). I feel the stock is now highly undervalued with a sub £2 million market cap. They have a NAV of 28p with a current share price of 10p. They have around £800,000 cash. They are invested in 23 quality companies who they will work each towards a profitable exit. I feel the share-price will quickly double and more during 2012. There will be plenty of newsflow due to the number of maturing companies they are working toward IPOs on. The chart isn't pretty but I feel this is due a bounce very soon. I have set up a new thread http://uk.advfn.com/cmn/fbb/thread.php3?id=26950477 with further information and links to their 23 investments. All are welcome. This is all my opinion and not intended to be investment advice. Thanks for your time. SC Read Full Thread Follow Reply

Braveheart Investment share price data is direct from the London Stock Exchange

add chat code

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:41 V: D:20180717 00:26:10